How should healthcare providers monitor patients receiving ivabradine therapy?

Indunil Karunarathna @Indunil-Karunarathna

05 May 2024 1 6K Report

How should healthcare providers monitor patients receiving ivabradine therapy?Article Ivabradine Therapy in Heart Failure Management: Optimizing O...

Indunil Karunarathna

Article Ivabradine Therapy in Heart Failure Management: Optimizing O...

Healthcare providers should monitor patients receiving ivabradine therapy through several means to ensure treatment efficacy and safety. Monitoring parameters include:

Cardiac Rhythm: Regular assessment of cardiac rhythm through electrocardiogram (ECG) monitoring can help detect any arrhythmias or changes in heart rhythm, especially atrial fibrillation, which may occur as a side effect of ivabradine.

Heart Rate: Monitoring of heart rate is essential to ensure that ivabradine is effectively reducing heart rate to the target range without causing excessive bradycardia. Patients should be instructed to monitor their resting heart rate regularly and report any significant changes or symptoms of bradycardia.

Symptoms of Bradycardia: Patients should be educated about the signs and symptoms of bradycardia, such as dizziness, fatigue, fainting, or shortness of breath. Healthcare providers should inquire about these symptoms during follow-up visits and adjust ivabradine dosage or discontinue treatment if necessary.

Visual Disturbances: Patients should be monitored for visual disturbances, such as phosphenes (perceived flashes of light), which may occur as a side effect of ivabradine. Patients experiencing visual disturbances should be evaluated, and treatment adjustments may be necessary.

Blood Pressure: Regular monitoring of blood pressure is recommended, as ivabradine may lead to elevated blood pressure in some patients.

Liver Function Tests: Periodic assessment of liver function tests may be warranted, especially in patients with underlying liver disease or risk factors for liver impairment.

Adverse Effects: Healthcare providers should inquire about any adverse effects or changes in symptoms during follow-up visits and address any concerns or issues related to ivabradine therapy.

Regular monitoring and communication between healthcare providers and patients are crucial to optimize ivabradine therapy, minimize adverse effects, and ensure patient safety and treatment efficacy.

Badges
Science topic

Similar topics
Eutheria
Rodentia
Muridae
Murinae
Mice

More Indunil Karunarathna's questions See All

Detection and Identification of Amanitins in the Wood-Rotting Fungi Galerina fasciculata andGalerina helvoliceps

Dear all, Can anyone help me to contact the corresponding author of the paper " Muraoka, S., Fukamachi, N., Mizumoto, K., & Shinozawa, T. (1999). Detection and Identification of Amanitins in...

01 January 1970 6,517 3 View

Edible mushrooms and their cultivation

Hi All, Does anyone have the PDF of following book? Chang, S. T.; Miles, P. G. (1989). Edible mushrooms and their cultivation. Edible Mushrooms and Their Cultivation, 345. Thanks

01 January 1970 7,851 1 View

Does anyone know an alternative product for cardiac Troponin T antibody for Immunofluorescence (Thermo # MA512960)?

We have been using Thermo Fisher anti-cardiac Troponin T antibody for immunofluorescence staining in FFPE mouse heart sections but it was recently discontinued. The literature shows it to be the...

01 March 2021 4,937 1 View

For modelling epoxy-based matrices (in composites), which model in ABAQUS is the most suitable, Concrete damaged plasticity or Drucker-Prager model?

I am working on developing a micromechanical FE model for predicting kink-band formation in UD composites. To model matrix plasticity, which model, out of Concrete Damaged Plasticity and...

28 February 2021 5,415 1 View

High aspect ratio hexahedral mesh optimization solver?

I am interested in evaluating mesh optimization solvers that converge to high aspect ratio unstructured hexahedral grids. In other words, I am interested in a solver that optimizes warpage,...

26 February 2021 7,279 2 View

How to interpolate from a time-series database ?

Hi, I am having trouble with a problem, in the field of Optimal Control and the generation of optimal time-series. Let's consider a system, whose dynamics are represented by dx/dt =...

24 February 2021 9,105 2 View

How can misfit between business requirents and ERP system business process be reduced?

One main reason for failure of most ERP implementations is the misfit between business requirents and ERP system business process be reduced. How can the misfit between business requirents and ERP...

22 February 2021 5,709 5 View

How COVID-19 has affected mental health?

The pandemic has led to depression and anxiety and its negative effects shouldn't be ignored. However, it has also led some people to become more resilient! What do you think? Thank you.

21 February 2021 4,733 19 View

Can medicinal plants really play an inherent rule in the COVID-19 tackle?

Numerous scientific reports cited plant extracts with potential antiviral activity and even anti-COVID-19? Why these findings are neglected? I remember very well the warning released by the WHO to...

17 February 2021 2,141 9 View

How to perform Kaplan-meier survival analysis in SPSS?

Hi everyone, This is my first time of attempting to run survival analysis. I have a data on patients with End-stage Kidney Diseases (ESKD). I would want to run survival probability by treatment...

16 February 2021 2,647 3 View

How can I interpret a ratio variable?

Dear colleagues, I am running a regression in which I have the following regression FoodExp = 67.04 DepRatio +.....e My interest is in the interpretation of the coefficient on the dependency...

16 February 2021 2,058 2 View

Is Genetic Algorithm usage for Motor Conception FEA optimization a good choice?

Hi RG community, Like the title shows ,i was wondering if choosing the GA for this kind of Optimizaiton is a good choice? For example we have a population of 100 (for 7-8 Optimization Variables),...

14 February 2021 1,160 7 View